In summary, the slow progressing phenotype of APPxhTau rats has unveiled the existence of an early, yet transient, stage of AD pathology during which tau appears to correct the synaptic dysfunction provoked by the intraneuronal accumulation of Aβ oligomers. This evidence concerns the gene MAPT and Alzheimer disease.